Ftse Mib
35.410,13
0,00%
DAX
18.738,81
-0,72%
S&P 500
5.297,10
-0,21%
NASDAQ
16.698,32
-0,26%
Bitcoin
65.496,22
0,39%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL) Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL) Notizie

PXSL

Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PXSL
DataOraFonteTitoloSimboloCompagnia
22/07/200912:04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
13/07/200901:22PR Newswire (US)Pharmaxis to Voluntarily De-List from NasdaqNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
30/06/200902:12PR Newswire (US)Pharmaxis Closes Share Purchase PlanNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
19/06/200914:56Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
16/06/200903:11PR Newswire (US)Phase 3 Cystic Fibrosis Trial Results Presented at European ConferenceNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
04/06/200902:19PR Newswire (US)Pharmaxis Announces Placement of $47 Million and Share Purchase PlanNASDAQ:PXSL
14/05/200901:33PR Newswire (US)U.S. FDA Accepts Aridol(TM) New Drug Application for ReviewNASDAQ:PXSL
04/05/200910:02PR Newswire (US)Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis TrialNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
07/04/200901:02PR Newswire (US)New Pharmaxis Board AppointmentNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
06/04/200909:52PR Newswire (US)Pharmaxis Investor Conference CallNASDAQ:PXSL
01/04/200900:58PR Newswire (US)Pharmaxis Announces Milestone in Phase III Trial for Cystic FibrosisNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
11/03/200907:10PR Newswire (US)Pharmaxis Appoints French Distributor for Aridol(TM)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
03/03/200915:14PR Newswire (US)Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test)NASDAQ:PXSL
01/03/200923:41PR Newswire (US)Pharmaxis Announces New Drug Application Submission for Aridol(TM)NASDAQ:PXSL
17/02/200914:22Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
17/02/200902:04PR Newswire (US)Pharmaxis Builds Senior Management TeamNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
20/10/200801:25PR Newswire (US)Pharmaxis Aridol Approved for Sale in SwitzerlandNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
03/10/200812:02Edgar (US Regulatory)Pharmaxis Ltd. - Report of Foreign Issuer (6-K)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
03/10/200802:26PR Newswire (US)Pharmaxis Research Programs Highlighted at European Respiratory Society CongressNASDAQ:PXSL
01/10/200802:19PR Newswire (US)ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in AustraliaNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
16/09/200812:05Edgar (US Regulatory)Pharmaxis Ltd. - Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
04/09/200808:33PR Newswire (US)Second Pivotal Phase 3 Trial In Cystic Fibrosis BeginsNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
20/08/200804:07PR Newswire (US)12 Month Phase 3 Trial Finds Bronchitol Safe in BronchiectasisNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
18/08/200803:59PR Newswire (US)Bronchitol Phase 3 Cystic Fibrosis Trial Completes RecruitmentNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
12/08/200802:10PR Newswire (US)Bronchitol Cystic Fibrosis Dose Trial Results PositiveNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
20/06/200801:05PR Newswire (US)Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 TrialNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
17/06/200803:20PR Newswire (US)Pharmaxis Establishes Named Patient Program for BronchitolNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
12/06/200801:47PR Newswire (US)Pharmaxis Long-Term Safety Study of Bronchitol CompletesNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
19/05/200804:13PR Newswire (US)Pharmaxis' Aridol Authorised for Sale in GermanyNASDAQ:PXSLPharmaxis Limited - Sponsored Adr (Australia) (MM)
01/05/200813:01PR Newswire (US)Regulatory Path for Bronchitol in BronchiectasisNASDAQ:PXSL
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PXSL

La tua Cronologia

EU
EDFCG
Electricity of France ED...
GATE
BSCSETH
BSCS Token
LSE
FH81
Cred Ag Co 27
NASDAQ
FSUZVX
Ft Equity Allocation Etf...
BIT
F35510
Vontobel Financial Produ...
BIT
F33499
Vontobel Financial Produ...
COIN
CVNXETH
CVNX
COIN
XGGGUSD
BIT
F39143
Vontobel Financial Produ...
COIN
COLLIEUST
Collie Token
GDAX
SYNUSD
Synapse
NYSE
WEBR
Weber
BIT
F37949
Vontobel Financial Produ...
BITMOT
809390
Ebrd Zc Ge26 Rub
UNSW3
T2LUSDT
Ticket2Lambo
COIN
DATXEUR
DATx
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network